Welcome to CDC Stacks | Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007 - 6872 | Stephen B. Thacker CDC Library collection | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
Filetype[PDF - 712.67 KB]

  • Corporate Authors:
    United States, Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.), Immunization Safety Office. ; ... More ▼
  • Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 56, no. RR-5
  • Document Type:
  • Description:
    Introduction -- Primary Changes and Updates in the Recommendations -- Influenza and Its Burden 3 -- Options for Controlling Influenza -- Comparison of LAIV with Inactivated Influenza Vaccine -- Cost-Effectiveness of Influenza Vaccine -- Vaccination Coverage Levels -- -- Recommendations for Using Inactivated and Live, Attenuated Influenza Vaccines -- Target Groups for Vaccination -- Additional Information Regarding Vaccination of Specific Populations -- Inactivated Influenza Vaccine Recommendations -- Live, Attenuated Influenza Vaccine Recommendations -- Recommended Vaccines for Different Age Groups -- Influenza Vaccine Supply and Timing of Annual Influenza Vaccination -- Strategies for Implementing Vaccination Recommendations in Health-Care Settings -- Future Directions for Research and Recommendations Related to Influenza Vaccine -- -- Recommendations for Using Antiviral Agents for Influenza -- Antiviral Agents for Influenza -- Role of Laboratory Diagnosis -- Antiviral Drug-Resistant Strains of Influenza Virus Indications for Use of Antivirals When Susceptibility Exists -- Dosage -- Route -- Pharmacokinetics -- Side Effects and Adverse Reactions -- Use During Pregnancy -- Drug Interactions -- -- Information Regarding the Vaccines for Children Program -- -- Sources of Information Regarding Influenza and Its Surveillance -- -- Reporting of Adverse Events Following Vaccination -- -- Additional Information Regarding Influenza Virus Infection Control Among Specific Populations -- -- References

    "This report updates the 2006 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2006;55[No. RR-10]). The groups of persons for whom vaccination is recommended and the antiviral medications recommended for chemoprophylaxis or treatment (oseltamivir or zanamivir) have not changed. Estimated vaccination coverage remains <50% among certain groups for whom routine annual vaccination is recommended, including young children and adults with risk factors for influenza complications, health-care personnel (HCP), and pregnant women. Strategies to improve vaccination coverage, including use of reminder/recall systems and standing orders programs, should be implemented or expanded. The 2007 recommendations include new and updated information. Principal updates and changes include 1) reemphasizing the importance of administering 2 doses of vaccine to all children aged 6 months--8 years if they have not been vaccinated previously at any time with either live, attenuated influenza vaccine (doses separated by >6 weeks) or trivalent inactivated influenza vaccine (doses separated by >4 weeks), with single annual doses in subsequent years; 2) recommending that children aged 6 months--8 years who received only 1 dose in their first year of vaccination receive 2 doses the following year, with single annual doses in subsequent years; 3) highlighting a previous recommendation that all persons, including school-aged children, who want to reduce the risk of becoming ill with influenza or of transmitting influenza to others should be vaccinated; 4) emphasizing that immunization providers should offer influenza vaccine and schedule immunization clinics throughout the influenza season; 5) recommending that health-care facilities consider the level of vaccination coverage among HCP to be one measure of a patient safety quality program and implement policies to encourage HCP vaccination (e.g., obtaining signed statements from HCP who decline influenza vaccination); and 6) using the 2007-2008 trivalent vaccine virus strains A/Solomon Islands/3/2006 (H1N1)-like (new for this season), A/Wisconsin/67/2005 (H3N2)-like, and B/Malaysia/2506/2004-like antigens. This report and other information are available at CDC's influenza website (http://www.cdc.gov/flu). Updates or supplements to these recommendations (e.g., expanded age or risk group indications for currently licensed vaccines) might be required. Immunization providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information." - p. 1

  • Supporting Files:
    No Additional Files